Iran Pharm.D. End-of-Course Exam study materials
Iran Pharm.D. End-of-Course Exam study resources

Iran Pharm.D. End-of-Course Exam: Biochemistry and Clinical Laboratory Sciences

Iran Pharm.D. End-of-Course Exam · Work through your exam, one topic at a time.

All guide sections

Biochemistry and Clinical Laboratory Sciences

What the exam tests

Biochemistry and Clinical Laboratory Sciences tests metabolic pathways, enzyme kinetics, and the interpretation of common laboratory tests.

Core rules

  • Michaelis–Menten: v = Vmax[S]/(Km + [S]). Km is the substrate concentration at half-Vmax; a lower Km means higher apparent affinity. Competitive inhibitors raise apparent Km; noncompetitive inhibitors lower Vmax.
  • Glycolysis yields 2 ATP and 2 NADH per glucose; the TCA cycle and oxidative phosphorylation yield most ATP. Uncouplers increase oxygen consumption but reduce ATP synthesis.
  • HbA1c reflects average glycemia over roughly 2–3 months. Estimated average glucose in mg/dL = 28.7 × A1c(%) − 46.7.
  • Anion gap = Na − (Cl + HCO3); normal is about 8–12 mEq/L. A high gap suggests organic acids, salicylate, methanol, or ethylene glycol.

Worked example

A patient has HbA1c 8.0%. Estimated average glucose = 28.7 × 8.0 − 46.7 = 229.6 − 46.7 = 182.9 mg/dL, about 183 mg/dL. The result is an estimate, not a measured mean, and is unreliable in hemoglobin variants, recent transfusion, or altered red-cell survival. If the fasting glucose is 250 mg/dL but the A1c is 6.5%, look for a discordant condition rather than assuming good control.

Traps

Do not interpret A1c as a fasting glucose; do not use anion gap without checking albumin; do not call an elevated AST specific for liver disease; and do not ignore hemolysis when potassium is spuriously high.